Skip to content

Author

Vasanth Kumar Mohan

We have 7 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Nanomedicine Approaches for Psoriasis: Advances in Topical Nanocarriers and Rna-based Delivery

Psoriasis is a chronic, immune-mediated inflammatory skin disease with a substantial impact on quality of life. Although systemic and conventional topical therapies are available, their efficacy is often modest, and their use is limited by systemic toxicity, poor cutaneous bioavailability, and low patient adherence...

Pavithra K. B., Iswariya V. T., Sundarajan R et al. · 0 citations
Review Oct 2026

Nanoparticle-Mediated Delivery of CRISPR/Cas9 Rnps Into Cells.

This review systematically evaluates recent advances in lipid-based, polymeric, peptide, and exosome-derived nanocarriers, focusing on their design principles, mechanisms of uptake, and endosomal escape strategies, and highlights both the promise and the limitations of nanoparticle-mediated CRISPR/Cas9 RNP delivery.

V. Rajeshwar, Konda Ravi Kumar, Gollapalli Rajeev Kumar et al. · 0 citations
Aug 2026

Optimized Lamotrigine-Loaded Polymeric Nanoparticles for Enhanced Drug Delivery: A Box-Behnken Design Approach with Integrated In Vivo Evaluation

Lamotrigine-loaded chitosan-sodium alginate polymeric nanoparticle system optimized by BoxBehnken Design demonstrated improved release control, enhanced pharmacokinetic parameters, and superior anticonvulsant activity in vivo, supporting their potential as a sustained-release system for epilepsy management.

D. R, J. B., K. M et al. · 0 citations
Review Aug 2026

Mechanistic and Translational Insights into Gold Nanoparticle-based Cancer Immunotherapy: A Quantitative Comparative Review of Opportunities and Toxicological Challenges

Advances in nanotechnology have produced a range of strategies for cancer treatment. Among the materials under investigation, Gold Nanoparticles (AuNPs) are attractive candidates for immunotherapy because of their distinctive physicochemical properties and biocompatibility. This narrative review draws on stu...

V. R. Jallepalli, Angum M. M. Ibrahim, Anasuya Patil et al. · 0 citations
Jul 2026

Enhancing Cancer Patient Outcomes using Theranostic Nanomedicine: Advances, Challenges, and Future Prospects.

Theranostic nanomedicine integrates diagnostic and therapeutic functions into a single nanoparticle, allowing clinicians to image a tumor and treat it with the same agent, and regulators have not agreed on how to classify combination nano-diagnostic-therapeutic products, so approval pathways are unclear.

B. E, Vivekanandan K, P. K. et al. · 0 citations
Review Jul 2026

Frontiers in Ocular Therapy: Linking Nanoparticles to Patho- Therapeutic Outcomes in Keratitis Treatment.

A critical review of the pathogenesis of microbial keratitis and a systematic assessment of emerging therapeutic approaches based on nanotechnology, including piezodynamic therapy, photothermal therapy, photodynamic therapy, photodynamic therapy, nanoenzymes, and metal ions are provided.

Ruchı Tıwarı, D. G, Vasanth Kumar Mohan et al. · 1 citation
#data science Review Nov 2026

Current Strategy for Implementing Advanced Tech to Address Multidrug Resistant Bacteria

These technologies offer promising alternatives to failing antibiotics, especially against pathogens with complex resistance mechanisms, however, limitations include toxicity concerns, immunological variability, immunological variability, lack of clinical validation, and cost barriers.

Rajeshwar Vodeti, V. Bakshi, Somasundaram Indirabanu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.